Gossypol/Phenformin (Haim Bio)

N/A

Report date: 2024/04/07 16:16:37
NME

Base Information

Drug NameGossypol/Phenformin (Haim Bio)
Drug Alias NameStarvanipGossypol+Phenformin (Haim Bio)NYH-817100NYH817G-NYH100PNYH817G+NYH100P
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsReactive oxygen species scavengers
TargetsReactive oxygen speciesProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes GossypolPhenformin Hydrochloride
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Center Of KoreaYonsei University Health SystemHaim Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHaim Bio Co LtdYonsei University Health SystemNational Cancer Center Of Korea
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A